Liver risk check
Fatty liver index calculator
The fatty liver index (FLI) turns four routine numbers into a 0 to 100 score for how likely it is that the liver holds extra fat. It is a research index built in one Italian town. It does not measure scarring, and it is not a diagnosis.
Your numbers
GGT (gamma-glutamyl transferase) is a liver enzyme on some liver panels. Triglycerides should be fasting. Nothing you enter leaves this page.
What you will see
Your fatty liver index from 0 to 100, which of the study's three ranges it falls in, and what that range meant in the study.
Educational only, not medical advice. The index cannot diagnose fatty liver or liver scarring.
Source
Bedogni G et al., BMC Gastroenterology 2006 (formula, coefficients and the 30 and 60 cut points).
Validated in
496 adults aged 18 to 75 from the Dionysos Nutrition & Liver Study in Campogalliano (Modena), northern Italy: 216 with and 280 without suspected liver disease, with fatty liver judged on ultrasound.
Limits
A research index for fat in the liver, not scarring. Checked against ultrasound, not biopsy, in one Italian town; the authors said it needed testing in other populations before use in practice. Not a diagnosis. Needs fasting triglycerides.
The formula
The index comes from a logistic regression model of four numbers, multiplied by 100 so it runs from 0 to 100 (Bedogni 2006):
L = 0.953 × ln(triglycerides, mg/dL) + 0.139 × BMI (kg/m²) + 0.718 × ln(GGT, U/L) + 0.053 × waist (cm) - 15.745
FLI = eL ÷ (1 + eL) × 100
Here ln is the natural log. If your lab reports triglycerides in mmol/L, we multiply by 88.57 to get mg/dL; a waist in inches is multiplied by 2.54. For example, triglycerides of 141 mg/dL, a BMI of 29.5, GGT of 31 U/L and a waist of 98 cm (the median values of the people with fatty liver in the study (Bedogni 2006)) give L = 0.73 and an index of about 68.
The researchers started with 13 candidate measures, including age, alcohol intake, ALT, AST, glucose, insulin and skinfolds, and kept the four that predicted fatty liver best and are measured routinely (Bedogni 2006). Waist size made the largest contribution, followed by BMI, triglycerides and GGT (Bedogni 2006). The final model had an accuracy (area under the curve) of 0.84 (Bedogni 2006).
The cut points: under 30 and 60 or more
| Index | What the study used it for | How it performed |
|---|---|---|
| Under 30 | Rule out fatty liver | Sensitivity 87%, negative likelihood ratio 0.2 (Bedogni 2006) |
| 30 to 59 | Neither ruled in nor out | No rule given in the paper (Bedogni 2006) |
| 60 or more | Rule in fatty liver | Specificity 86%, positive likelihood ratio 4.3 (Bedogni 2006) |
In plain words: of the people in the study who had fatty liver on ultrasound, 87% scored 30 or more, so a score under 30 made fatty liver less likely. Of those without it, 86% scored under 60, so a score of 60 or more made it more likely (Bedogni 2006). These numbers come from the same group the index was built in, which tends to make a test look better than it will elsewhere.
A research index, with limits
The authors suggested the index could help doctors choose who to send for an ultrasound and who might gain from more lifestyle advice, and help researchers pick people for studies. They also wrote that it is very important to validate it in other populations before it is used in practice (Bedogni 2006). They named two limits of their study: only 58% of the town's residents took part, and ultrasound cannot tell plain fat from fat with inflammation (steatohepatitis) (Bedogni 2006).
Ultrasound itself misses smaller amounts of fat, especially in people with obesity, and a liver that looks normal on ultrasound can still have inflammation or scarring (AASLD 2023). Because the index was built to match ultrasound findings, it shares those blind spots.
Fat is not scarring: FIB-4 comes first
The question that matters most in fatty liver disease is whether the liver is scarred (fibrosis) (AASLD 2023). The fatty liver index does not answer it. The American Association for the Study of Liver Diseases recommends FIB-4 as the first test for advanced scarring (AASLD 2023). If you have AST, ALT and a platelet count, use the FIB-4 calculator. The NAFLD fibrosis score is a second scarring score for people who already have fatty liver disease.
Who should think about this
Fatty liver disease is common in people with overweight, type 2 diabetes or high blood pressure, and usually has no symptoms (NIDDK). NIDDK estimates that about 24% of US adults have it (NIDDK). Read fatty liver disease (MASLD), explained for the background. Several of the index's inputs also track insulin resistance: the TyG index calculator uses fasting triglycerides and glucose, and the waist-to-height ratio looks at waist size on its own, and the lipid accumulation product combines waist size with fasting triglycerides. The hepatic steatosis index is another research index for liver fat, built in Korea from ALT, AST, BMI, sex and diabetes. A high index is a reason to talk to your doctor, not a diagnosis.
Sources
- Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. PMID 17081293. doi.org/10.1186/1471-230X-6-33
- Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797-1835. doi.org/10.1097/HEP.0000000000000323
- National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Nonalcoholic Fatty Liver Disease (NAFLD) and NASH. www.niddk.nih.gov/health-information/liver-disease/nafld-nash
- National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Definition and Facts of NAFLD and NASH (MASLD and MASH). www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts
Written and maintained by the uncovermyrisk.com editorial team. We do not have a medical reviewer; every claim links to its primary source above. Last reviewed: 2026-11-01. Spotted an error? See About.